Preimplantation Genetic Testing

PGT enables your clinical team to select chromosomally healthy embryos before transfer, significantly increasing implantation rates and reducing the risk of miscarriage or inherited conditions.

• PGT-A (Aneuploidies) — Screens all 24 chromosome pairs to identify euploid embryos most likely to implant successfully.
• PGT-M (Monogenic Disorders) — Custom test designed for families at risk of single-gene disorders such as thalassemia, cystic fibrosis, or BRCA mutations.
• PGT-SR (Structural Rearrangements) — Identifies unbalanced chromosomal rearrangements in embryos from carriers of translocations or inversions.
• Trophectoderm Biopsy — Day-5 blastocyst biopsy minimises developmental disruption while providing reliable genetic data.
• Next-Generation Sequencing — NGS platforms used by our partner labs provide high-resolution chromosomal analysis with validated accuracy.